August 01, 2018
A New Jersey federal judge said Tuesday that Valeant Pharmaceuticals International Inc. will have to face Racketeer Influenced and Corrupt Organizations Act claims filed against it, its executives and PricewaterhouseCoopers in three separate lawsuits alleging Valeant inflated its stock price through unsavory and deceptive business practices.